Your browser doesn't support javascript.
loading
Inhibition of SARS-CoV-2 nucleocapsid protein-RNA interaction by guanosine oligomeric RNA.
Sekine, Ryoya; Tsuno, Satsuki; Irokawa, Hayato; Sumitomo, Kazuhiro; Han, Tianxue; Sato, Yusuke; Nishizawa, Seiichi; Takeda, Kouki; Kuge, Shusuke.
Afiliação
  • Sekine R; Division of Microbiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1, Komatsuhima, Aoba-ku, Sendai, Miyagi 981-8558, Japan.
  • Tsuno S; Division of Microbiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1, Komatsuhima, Aoba-ku, Sendai, Miyagi 981-8558, Japan.
  • Irokawa H; Division of Microbiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1, Komatsuhima, Aoba-ku, Sendai, Miyagi 981-8558, Japan.
  • Sumitomo K; Division of Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1, Fukumuro, Miyagino-ku, Sendai, Miyagi 983-8536, Japan.
  • Han T; Department of Chemistry, Graduate School of Science, Tohoku University, 6-3, Azaaoba, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
  • Sato Y; Department of Chemistry, Graduate School of Science, Tohoku University, 6-3, Azaaoba, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
  • Nishizawa S; Department of Chemistry, Graduate School of Science, Tohoku University, 6-3, Azaaoba, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
  • Takeda K; Division of Microbiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1, Komatsuhima, Aoba-ku, Sendai, Miyagi 981-8558, Japan.
  • Kuge S; Division of Microbiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1, Komatsuhima, Aoba-ku, Sendai, Miyagi 981-8558, Japan.
J Biochem ; 173(6): 447-457, 2023 May 29.
Article em En | MEDLINE | ID: mdl-36748338
ABSTRACT
The interaction of the ß-coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) nucleocapsid (N) protein with genomic RNA is initiated by specific RNA regions and subsequently induces the formation of a continuous polymer with characteristic structural units for viral formation. We hypothesized that oligomeric RNAs, whose sequences are absent in the 29.9-kb genome sequence of SARS-CoV-2, might affect RNA-N protein interactions. We identified two such hexameric RNAs, In-1 (CCGGCG) and G6 (GGGGGG), and investigated their effects on the small filamentous/droplet-like structures (< a few µm) of N protein-genomic RNA formed by liquid-liquid phase separation. The small N protein structures were sequence-specifically enhanced by In-1, whereas G6 caused them to coalesce into large droplets. Moreover, we found that a guanosine 12-mer (G12, GGGGGGGGGGGG) expelled preexisting genomic RNA from the small N protein structures. The presence of G12 with the genomic RNA suppressed the formation of the small N protein structures, and alternatively apparently altered phase separation to induce the formation of large droplets with unclear phase boundaries. We showed that the N-terminal RNA-binding domain is required for the stability of the small N protein structures. Our results suggest that G12 may be a strong inhibitor of the RNA-N protein interaction.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article